<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39309400</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2468-0427</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Infectious Disease Modelling</Title><ISOAbbreviation>Infect Dis Model</ISOAbbreviation></Journal><ArticleTitle>A novel comparison framework for epidemiological strategies applied to age-based restrictions versus horizontal lockdowns.</ArticleTitle><Pagination><StartPage>1301</StartPage><EndPage>1328</EndPage><MedlinePgn>1301-1328</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.idm.2024.07.002</ELocationID><Abstract><AbstractText>During an epidemic, such as the COVID-19 pandemic, policy-makers are faced with the decision of implementing effective, yet socioeconomically costly intervention strategies, such as school and workplace closure, physical distancing, etc. In this study, we propose a rigorous definition of epidemiological strategies. In addition, we develop a scheme for comparing certain epidemiological strategies, with the goal of providing policy-makers with a tool for their systematic comparison. Then, we put the suggested scheme to the test by employing an age-based epidemiological compartment model introduced in Bitsouni et al. (2024), coupled with data from the literature, in order to compare the effectiveness of age-based and horizontal interventions. In general, our findings suggest that these two are comparable, mainly at a low or medium level of intensity.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bitsouni</LastName><ForeName>Vasiliki</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Mathematics, University of Patras, GR-26504, Rio Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gialelis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Mathematics, National and Kapodistrian University of Athens, GR-15784, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, National and Kapodistrian University of Athens, GR-11527, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsilidis</LastName><ForeName>Vasilis</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Mathematics, University of Patras, GR-26504, Rio Patras, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Infect Dis Model</MedlineTA><NlmUniqueID>101692406</NlmUniqueID><ISSNLinking>2468-0427</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aged-based interventions</Keyword><Keyword MajorTopicYN="N">Asymptomatic infectious</Keyword><Keyword MajorTopicYN="N">Basic reproductive number</Keyword><Keyword MajorTopicYN="N">Comparison scheme</Keyword><Keyword MajorTopicYN="N">Epidemiological strategy</Keyword><Keyword MajorTopicYN="N">Horizontal restrictions</Keyword><Keyword MajorTopicYN="N">Numerical simulations 2020 MSC: 35Q92, 37N25, 92-10, 92D30</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39309400</ArticleId><ArticleId IdType="pmc">PMC11415861</ArticleId><ArticleId IdType="doi">10.1016/j.idm.2024.07.002</ArticleId><ArticleId IdType="pii">S2468-0427(24)00091-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abell I.R., McCaw J.M., Baker C.M. Understanding the impact of disease and vaccine mechanisms on the importance of optimal vaccine allocation. Infectious Disease Modelling. 2023;8:539–550. doi: 10.1016/j.idm.2023.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2023.05.003</ArticleId><ArticleId IdType="pmc">PMC10241858</ArticleId><ArticleId IdType="pubmed">37288288</ArticleId></ArticleIdList></Reference><Reference><Citation>Acemoglu D., Chernozhukov V., Werning I., Whinston M.D. Optimal targeted lockdowns in a multigroup sir model. The American Economic Review: Insights. 2021;3:487–502. doi: 10.1257/aeri.20200590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1257/aeri.20200590</ArticleId></ArticleIdList></Reference><Reference><Citation>Adegbite G., Edeki S., Isewon I., Emmanuel J., Dokunmu T., Rotimi S., Oyelade J., Adebiyi E. Mathematical modeling of malaria transmission dynamics in humans with mobility and control states. Infectious Disease Modelling. 2023;8:1015–1031. doi: 10.1016/j.idm.2023.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2023.08.005</ArticleId><ArticleId IdType="pmc">PMC10463202</ArticleId><ArticleId IdType="pubmed">37649792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahammed T., Anjum A., Rahman M.M., Haider N., Kock R., Uddin M.J. Estimation of novel coronavirus (COVID-19) reproduction number and case fatality rate: A systematic review and meta-analysis. Health Science Reports. 2021;4:e274. doi: 10.1002/hsr2.274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.274</ArticleId><ArticleId IdType="pmc">PMC8093857</ArticleId><ArticleId IdType="pubmed">33977156</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaku M., Covas D.T., Coutinho F.A.B., Neto R.S.A., Struchiner C., Wilder-Smith A., Massad E. Modelling the test, trace and quarantine strategy to control the COVID-19 epidemic in the state of São Paulo, Brazil. Infectious Disease Modelling. 2021;6:46–55. doi: 10.1016/j.idm.2020.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2020.11.004</ArticleId><ArticleId IdType="pmc">PMC7677040</ArticleId><ArticleId IdType="pubmed">33235942</ArticleId></ArticleIdList></Reference><Reference><Citation>Anupong S., Chantanasaro T., Wilasang C., Jitsuk N.C., Sararat C., Sornbundit K., Pattanasiri B., Wannigama D.L., Amarasiri M., Chadsuthi S., Modchang C. Modeling vaccination strategies with limited early COVID-19 vaccine access in low-and middle-income countries: A case study of Thailand. Infectious Disease Modelling. 2023;8:1177–1189. doi: 10.1016/j.idm.2023.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2023.11.003</ArticleId><ArticleId IdType="pmc">PMC10709621</ArticleId><ArticleId IdType="pubmed">38074078</ArticleId></ArticleIdList></Reference><Reference><Citation>Apenteng O.O., Osei P.P., Oduro B., Kwabla M.P., Ismail N.A. The impact of implementing HIV prevention policies therapy and control strategy among HIV and AIDS incidence cases in Malaysia. Infectious Disease Modelling. 2020;5:755–765. doi: 10.1016/j.idm.2020.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2020.09.009</ArticleId><ArticleId IdType="pmc">PMC7536735</ArticleId><ArticleId IdType="pubmed">33073067</ArticleId></ArticleIdList></Reference><Reference><Citation>Asahi K., Undurraga E.A., Valdés R., Wagner R. The effect of COVID-19 on the economy: Evidence from an early adopter of localized lockdowns. Journal of Global Health. 2021;11 doi: 10.7189/jogh.10.05002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.10.05002</ArticleId><ArticleId IdType="pmc">PMC7897430</ArticleId><ArticleId IdType="pubmed">33643635</ArticleId></ArticleIdList></Reference><Reference><Citation>Béraud G., Timsit J.-F., Leleu H. Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact. PLoS One. 2022;17 doi: 10.1371/journal.pone.0262462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0262462</ArticleId><ArticleId IdType="pmc">PMC8754316</ArticleId><ArticleId IdType="pubmed">35020746</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhadauria A.S., Dhungana H.N., Verma V., Woodcock S., Rai T. Studying the efficacy of isolation as a control strategy and elimination of tuberculosis in India: A mathematical model. Infectious Disease Modelling. 2023;8:458–470. doi: 10.1016/j.idm.2023.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2023.03.005</ArticleId><ArticleId IdType="pmc">PMC10206434</ArticleId><ArticleId IdType="pubmed">37234098</ArticleId></ArticleIdList></Reference><Reference><Citation>Billah M.A., Miah M.M., Khan M.N. Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence. PLoS One. 2020;15 doi: 10.1371/journal.pone.0242128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0242128</ArticleId><ArticleId IdType="pmc">PMC7657547</ArticleId><ArticleId IdType="pubmed">33175914</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitsouni V., Gialelis N., Tsilidis V. An age-structured SVEAIR epidemiological model. Mathematical Methods in the Applied Sciences. 2024 doi: 10.1002/mma.10165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mma.10165</ArticleId></ArticleIdList></Reference><Reference><Citation>Brethouwer J.-T., van de Rijt A., Lindelauf R., Fokkink R. “Stay nearby or get checked”: A covid-19 control strategy. Infectious Disease Modelling. 2021;6:36–45. doi: 10.1016/j.idm.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2020.10.013</ArticleId><ArticleId IdType="pmc">PMC7669247</ArticleId><ArticleId IdType="pubmed">33225114</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodeur A., Gray D., Islam A., Bhuiyan S. A literature review of the economics of COVID-19. Journal of Economic Surveys. 2021;35:1007–1044. doi: 10.1111/joes.12423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joes.12423</ArticleId><ArticleId IdType="pmc">PMC8250825</ArticleId><ArticleId IdType="pubmed">34230772</ArticleId></ArticleIdList></Reference><Reference><Citation>Buitrago-Garcia D., Ipekci A.M., Heron L., Imeri H., Araujo-Chaveron L., Arevalo-Rodriguez I., Ciapponi A., Cevik M., Hauser A., Alam M.I., et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis. PLoS Medicine. 2022;19 doi: 10.1371/journal.pmed.1003987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003987</ArticleId><ArticleId IdType="pmc">PMC9135333</ArticleId><ArticleId IdType="pubmed">35617363</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne A.W., McEvoy D., Collins A.B., Hunt K., Casey M., Barber A., Butler F., Griffin J., Lane E.A., McAloon C., et al. Inferred duration of infectious period of SARS-CoV-2: Rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases. BMJ Open. 2020;10 doi: 10.1136/bmjopen-2020-039856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-039856</ArticleId><ArticleId IdType="pmc">PMC7409948</ArticleId><ArticleId IdType="pubmed">32759252</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for disease control and prevention. 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html URL:</Citation></Reference><Reference><Citation>Chau N.V.V., Nguyet L.A., Truong N.T., Dung N.T., Nhan M.T., Man D.N.H., Ngoc N.M., Thao H.P., Tu T.N.H., Mai H.K., et al. Immunogenicity of Oxford-AstraZeneca COVID-19 vaccine in Vietnamese health-care workers. The American Journal of Tropical Medicine and Hygiene. 2022;106:556. doi: 10.4269/ajtmh.21-0849.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.21-0849</ArticleId><ArticleId IdType="pmc">PMC8832887</ArticleId><ArticleId IdType="pubmed">34996048</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Vullikanti A., Santos J., Venkatramanan S., Hoops S., Mortveit H., Lewis B., You W., Eubank S., Marathe M., et al. Epidemiological and economic impact of COVID-19 in the US. Scientific Reports. 2021;11 doi: 10.1038/s41598-021-99712-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-99712-z</ArticleId><ArticleId IdType="pmc">PMC8517017</ArticleId><ArticleId IdType="pubmed">34650141</ArticleId></ArticleIdList></Reference><Reference><Citation>Deb P., Furceri D., Ostry J.D., Tawk N. The economic effects of COVID-19 containment measures. Open Economies Review. 2021;33:1–32. doi: 10.1007/s11079-021-09638-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11079-021-09638-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle S., Hyman J., Hethcote H., Eubank S. Mixing patterns between age groups in social networks. Social Networks. 2007;29:539–554. doi: 10.1016/j.socnet.2007.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socnet.2007.04.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Demers J., Fagan W.F., Potluri S., Calabrese J.M. The relationship between controllability, optimal testing resource allocation, and incubation-latent period mismatch as revealed by COVID-19. Infectious Disease Modelling. 2023;8:514–538. doi: 10.1016/j.idm.2023.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2023.04.007</ArticleId><ArticleId IdType="pmc">PMC10186984</ArticleId><ArticleId IdType="pubmed">37250860</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekmann O., Heesterbeek J.A.P. ume 5. John Wiley &amp; Sons; 2000. (Mathematical epidemiology of infectious diseases: Model building, analysis and interpretation).</Citation></Reference><Reference><Citation>Gan G., Janhavi A., Tong G., Lim J.T., Dickens B.L. The need for pre-emptive control strategies for mpox in Asia and Oceania. Infectious Disease Modelling. 2024;9:214–223. doi: 10.1016/j.idm.2023.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2023.12.005</ArticleId><ArticleId IdType="pmc">PMC10825486</ArticleId><ArticleId IdType="pubmed">38293686</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z., Xu Y., Sun C., Wang X., Guo Y., Qiu S., Ma K. A systematic review of asymptomatic infections with COVID-19. Journal of Microbiology, Immunology, and Infection. 2021;54:12–16. doi: 10.1016/j.jmii.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7227597</ArticleId><ArticleId IdType="pubmed">32425996</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant R., Charmet T., Schaeffer L., Galmiche S., Madec Y., Von Platen C., Chény O., Omar F., David C., Rogoff A., et al. Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France. The Lancet Regional Health - Europe. 2022;13 doi: 10.1016/j.lanepe.2021.100278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100278</ArticleId><ArticleId IdType="pmc">PMC8616730</ArticleId><ArticleId IdType="pubmed">34849500</ArticleId></ArticleIdList></Reference><Reference><Citation>He J., Guo Y., Mao R., Zhang J. Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis. Journal of Medical Virology. 2021;93:820–830. doi: 10.1002/jmv.26326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26326</ArticleId><ArticleId IdType="pmc">PMC7404334</ArticleId><ArticleId IdType="pubmed">32691881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang M., Xin H., Yuan J., Ali S.T., Liang Z., Zhang J., Hu T., Lau E.H., Zhang Y., Zhang M., et al. Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021. Euro Surveillance. 2022;27 doi: 10.2807/1560-7917.ES.2022.27.10.2100815.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.10.2100815</ArticleId><ArticleId IdType="pmc">PMC8915401</ArticleId><ArticleId IdType="pubmed">35272744</ArticleId></ArticleIdList></Reference><Reference><Citation>Karatayev V.A., Anand M., Bauch C.T. Local lockdowns outperform global lockdown on the far side of the COVID-19 epidemic curve. Proceedings of the National Academy of Sciences. 2020;117:24575–24580. doi: 10.1073/pnas.2014385117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2014385117</ArticleId><ArticleId IdType="pmc">PMC7533690</ArticleId><ArticleId IdType="pubmed">32887803</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirwin E., Rafferty E., Harback K., Round J., McCabe C. A net benefit approach for the optimal allocation of a covid-19 vaccine. PharmacoEconomics. 2021;39:1059–1073. doi: 10.1007/s40273-021-01037-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-021-01037-2</ArticleId><ArticleId IdType="pmc">PMC8209775</ArticleId><ArticleId IdType="pubmed">34138458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamba S., Das T., Srivastava P.K. Impact of infectious density-induced additional screening and treatment saturation on COVID-19: Modeling and cost-effective optimal control. Infectious Disease Modelling. 2024;9:569–600. doi: 10.1016/j.idm.2024.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2024.03.002</ArticleId><ArticleId IdType="pmc">PMC10978547</ArticleId><ArticleId IdType="pubmed">38558959</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu E., Ritchie H., Rodés-Guirao L., Appel C., Giattino C., Hasell J., Macdonald B., Dattani S., Beltekian D., Ortiz-Ospina E., Roser M. Coronavirus pandemic (COVID-19), our World in Data. 2020. https://ourworldindata.org/coronavirus</Citation></Reference><Reference><Citation>Motorniak D., Savulescu J., Giubilini A. Reelin’in the years: Age and selective restriction of liberty in the COVID-19 pandemic. Journal of bioethical inquiry. 2023:1–9. doi: 10.1007/s11673-023-10318-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11673-023-10318-8</ArticleId><ArticleId IdType="pmc">PMC10943133</ArticleId><ArticleId IdType="pubmed">38047996</ArticleId></ArticleIdList></Reference><Reference><Citation>Owusu-Dampare F., Bouchnita A. Equitable bivalent booster allocation strategies against emerging SARS-CoV-2 variants in US cities with large Hispanic communities: The case of El Paso County, Texas. Infectious Disease Modelling. 2023;8:912–919. doi: 10.1016/j.idm.2023.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2023.07.009</ArticleId><ArticleId IdType="pmc">PMC10400804</ArticleId><ArticleId IdType="pubmed">37547263</ArticleId></ArticleIdList></Reference><Reference><Citation>Patón M., Acuña J.M., Rodríguez J. Evaluation of vaccine rollout strategies for emerging infectious diseases: A model-based approach including protection attitudes. Infectious Disease Modelling. 2023;8:1032–1049. doi: 10.1016/j.idm.2023.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2023.07.012</ArticleId><ArticleId IdType="pmc">PMC10477745</ArticleId><ArticleId IdType="pubmed">37674584</ArticleId></ArticleIdList></Reference><Reference><Citation>Perra N. Non-pharmaceutical interventions during the COVID-19 pandemic: A review. Physics Reports. 2021;913:1–52. doi: 10.1016/j.physrep.2021.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physrep.2021.02.001</ArticleId><ArticleId IdType="pmc">PMC7881715</ArticleId><ArticleId IdType="pubmed">33612922</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollock A.M., Lancaster J. Asymptomatic transmission of covid-19. BMJ. 2020;371 doi: 10.1136/bmj.m4851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4851</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohatgi A. Version 4.6Webplotdigitizer. 2022 https://automeris.io/WebPlotDigitizer</Citation></Reference><Reference><Citation>SAGE 56th meeting on COVID-19. 2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/928699/S0740_Fifty-sixth_SAGE_meeting_on_Covid-19.pdf</Citation></Reference><Reference><Citation>Sah P., Fitzpatrick M.C., Zimmer C.F., Abdollahi E., Juden-Kelly L., Moghadas S.M., Singer B.H., Galvani A.P. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis. Proceedings of the National Academy of Sciences. 2021;118 doi: 10.1073/pnas.2109229118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2109229118</ArticleId><ArticleId IdType="pmc">PMC8403749</ArticleId><ArticleId IdType="pubmed">34376550</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha A.K., Saha S., Podder C.N. Effect of awareness, quarantine and vaccination as control strategies on Covid-19 with co-morbidity and re-infection. Infectious Disease Modelling. 2022;7:660–689. doi: 10.2139/ssrn.4185141.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4185141</ArticleId><ArticleId IdType="pmc">PMC9574606</ArticleId><ArticleId IdType="pubmed">36276578</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlosser F., Maier B.F., Jack O., Hinrichs D., Zachariae A., Brockmann D. COVID-19 lockdown induces disease-mitigating structural changes in mobility networks. Proceedings of the National Academy of Sciences. 2020;117:32883–32890. doi: 10.1073/pnas.2012326117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2012326117</ArticleId><ArticleId IdType="pmc">PMC7776901</ArticleId><ArticleId IdType="pubmed">33273120</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni A., Herbert C., Lin H., Yan Y., Pretz C., Stamegna P., Wang B., Orwig T., Wright C., Tarrant S., et al. Performance of rapid Antigen tests to detect symptomatic and asymptomatic SARS-CoV-2 infection: A prospective cohort study. Annals of Internal Medicine. 2023;176:975–982. doi: 10.7326/M23-0385.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M23-0385</ArticleId><ArticleId IdType="pmc">PMC10321467</ArticleId><ArticleId IdType="pubmed">37399548</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaccatini F., Giovannelli I., Pacilli M.G. “You are stealing our present”: Younger people's ageism towards older people predicts attitude towards age-based COVID-19 restriction measures. Journal of Social Issues. 2022;78:769–789. 10.1111/josi. 12537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538229</ArticleId><ArticleId IdType="pubmed">36249551</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan W., Wong L., Leo Y., Toh M. Does incubation period of COVID-19 vary with age? A study of epidemiologically linked cases in Singapore. Epidemiology and Infection. 2020;148:e197. doi: 10.1017/S0950268820001995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268820001995</ArticleId><ArticleId IdType="pmc">PMC7484300</ArticleId><ArticleId IdType="pubmed">32873357</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongtha A., Modnak C. Optimal COVID-19 epidemic strategy with vaccination control and infection prevention measures in Thailand. Infectious Disease Modelling. 2022;7:835–855. doi: 10.1016/j.idm.2022.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2022.11.002</ArticleId><ArticleId IdType="pmc">PMC9678212</ArticleId><ArticleId IdType="pubmed">36438694</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rens T., Oswald A.J. Age-based policy in the context of the covid-19 pandemic: How common are multigenerational households? CAGE Online Working Paper Series. 2020</Citation></Reference><Reference><Citation>Vatcheva K.P., Sifuentes J., Oraby T., Maldonado J.C., Huber T., Villalobos M.C. Social distancing and testing as optimal strategies against the spread of COVID-19 in the Rio Grande Valley of Texas. Infectious Disease Modelling. 2021;6:729–742. doi: 10.1016/j.idm.2021.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2021.04.004</ArticleId><ArticleId IdType="pmc">PMC8065238</ArticleId><ArticleId IdType="pubmed">33937596</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma V.R., Saini A., Gandhi S., Dash U., Koya S.F. Capacity-need gap in hospital resources for varying mitigation and containment strategies in India in the face of COVID-19 pandemic. Infectious Disease Modelling. 2020;5:608–621. doi: 10.1016/j.idm.2020.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2020.08.011</ArticleId><ArticleId IdType="pmc">PMC7452840</ArticleId><ArticleId IdType="pubmed">32875175</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Balboni E., Rothman K.J., Teggi S., Bellino S., Pezzotti P., Ferrari F., Orsini N., Filippini T. Substantial impact of mobility restrictions on reducing COVID-19 incidence in Italy in 2020. Journal of Travel Medicine. 2022;29 doi: 10.1093/jtm/taac081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taac081</ArticleId><ArticleId IdType="pmc">PMC9384467</ArticleId><ArticleId IdType="pubmed">35876268</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfram Research Inc.  Mathematica. 2022 https://www.wolfram.com/mathematica Version 13.1.</Citation></Reference><Reference><Citation>Wu Y., Kang L., Guo Z., Liu J., Liu M., Liang W. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: A systematic review and meta-analysis. JAMA Network Open. 2022;5 doi: 10.1001/jamanetworkopen.2022.28008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.28008</ArticleId><ArticleId IdType="pmc">PMC9396366</ArticleId><ArticleId IdType="pubmed">35994285</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakary O., Rachik M., Elmouki I. A new epidemic modeling approach: Multi-regions discrete-time model with travel-blocking vicinity optimal control strategy. Infectious Disease Modelling. 2017;2:304–322. doi: 10.1016/j.idm.2017.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idm.2017.06.003</ArticleId><ArticleId IdType="pmc">PMC6002029</ArticleId><ArticleId IdType="pubmed">29928744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaman G., Kang Y.H., Jung I.H. Optimal treatment of an SIR epidemic model with time delay. Biosystems. 2009;98:43–50. doi: 10.1016/j.biosystems.2009.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biosystems.2009.05.006</ArticleId><ArticleId IdType="pubmed">19464340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Xu R., Hu D., Yue Y., Li Q., Xia J. Effects of human mobility restrictions on the spread of COVID-19 in shenzhen, China: A modelling study using mobile phone data. The Lancet Digital Health. 2020;2:e417–e424. doi: 10.1016/S2589-7500(20).30165-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(20).30165-5</ArticleId><ArticleId IdType="pmc">PMC7384783</ArticleId><ArticleId IdType="pubmed">32835199</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>